CTRP3 modulates the expression and secretion of adipokines in 3T3-L1 adipocytes

Endocrine Journal

Volumn 61, Issue 12, 2014, Pages 1153-1162

  Li, Xin ^a   Jiang, L ^a   Yang, Miao ^a   Wu, Yu Wen ^a   Sun, Su Xin ^a   Sun, Jia Zhong ^a  

^a WUHAN UNIVERSITY   (China)

Author keywords

3T3 L1 adipocytes; Adipokines; AMPK; C1q TNF related protein 3; Insulin resistance

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; APELIN; C1Q TNF RELATED PROTEIN 3; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; LEPTIN; MESSENGER RNA; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; UNCLASSIFIED DRUG; (6-(4-(2-PIPERIDIN-1-YLETHOXY)PHENYL))-3-PYRIDIN-4-YLPYRAZOLO(1,5-A)PYRIMIDINE; APLN PROTEIN, MOUSE; CORS26 PROTEIN, MOUSE; CYTOKINE; GLUCOSE; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE, MOUSE; PROTEIN KINASE INHIBITOR; PYRAZOLE DERIVATIVE; PYRIMIDINE DERIVATIVE; RECOMBINANT PROTEIN; SIGNAL PEPTIDE;

ADIPOCYTE; ADIPONECTIN GENE; APELIN GENE; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME MECHANISM; GENE EXPRESSION; INSULIN RESISTANCE; LEPTIN GENE; PROTEIN EXPRESSION; PROTEIN SECRETION; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UPREGULATION; VISFATIN GENE; WESTERN BLOTTING; 3T3 CELL LINE; ANIMAL; ANTAGONISTS AND INHIBITORS; CHEMISTRY; DRUG EFFECTS; GENETICS; IMMUNOLOGY; KINETICS; METABOLISM; MOUSE; SECRETION (PROCESS); WHITE ADIPOCYTE;

3T3-L1 CELLS; ADIPOCYTES, WHITE; ADIPOKINES; AMP-ACTIVATED PROTEIN KINASES; ANIMALS; CYTOKINES; GLUCOSE; INSULIN RESISTANCE; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; KINETICS; MICE; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; PROTEIN KINASE INHIBITORS; PYRAZOLES; PYRIMIDINES; RECOMBINANT PROTEINS; SIGNAL TRANSDUCTION; UP-REGULATION;

EID: 84919785889     PISSN: 09188959     EISSN: 13484540     Source Type: Journal    
DOI: 10.1507/endocrj.EJ14-0161     Document Type: Article

References (21)

1. Leal Vde O, Mafra D (2013) Adipokines in obesity. Clin Chim Acta 419: 87-94.
2. Ouchi N, Parker JL, Lugus JJ, Walsh K (2011) Adipokines in inflammation and metabolic disease. Nat Rev Immunol 11:85-97.
3. Ye R, Scherer PE (2013) Adiponectin, driver or passenger on the road to insulin sensitivity? Mol Metab 2:133- 141.
4. Jung CH, Kim MS (2013) Molecular mechanisms of central leptin resistance in obesity. Arch Pharm Res 36:201-207.
5. Stastny J, Bienertova-Vasku J, Vasku A (2012) Visfatin and its role in obesity development. Diabetes Metab Syndr 6:120-124.
6. Sawane M, Kajiya K, Kidoya H, Takagi M, Muramatsu F, et al. (2013) Apelin inhibits diet-induced obesity by enhancing lymphatic and blood vessel integrity. Diabetes 62:1970-1980.
7. Kishore U, Gaboriaud C, Waters P, Shrive AK, Greenhough TJ, et al. (2004) C1q and tumor necrosis factor superfamily: modularity and versatility. Trends Immunol 25:551-561.
8. Peterson JM, Wei Z, Wong GW (2010) C1q/TNFrelated protein-3 (CTRP3), a novel adipokine that regulates hepatic glucose output. J Biol Chem 285: 39691- 39701.
9. Kopp A, Bala M, Buechler C, Falk W, Gross P, et al. (2010) C1q/TNF-related protein-3 represents a novel and endogenous lipopolysaccharide antagonist of the adipose tissue. Endocrinology 151:5267-5278.
10. Yoo HJ, Hwang SY, Hong HC, Choi HY, Yang SJ, et al. (2013) Implication of progranulin and C1q/TNF-related protein-3 (CTRP3) on inflammation and atherosclerosis in subjects with or without metabolic syndrome. PLoS One 8:e55744.
11. Wölfing B, Buechler C, Weigert J, Neumeier M, Aslanidis C, et al. (2008) Effects of the new C1q/TNFrelated protein (CTRP-3) “cartonectin” on the adipocytic secretion of adipokines. Obesity (Silver Spring) 16:1481-1486.
12. Ye J (2013) Mechanisms of insulin resistance in obesity. Front Med 7:14-24.
13. Nawrocki AR, Rajala MW, Tomas E, Pajvani UB, Saha AK, et al. (2006) Mice lacking adiponectin show decreased hepatic insulin sensitivity and reduced responsiveness to peroxisome proliferator-activated receptor gamma agonists. J Biol Chem 281: 2654-2660.
14. Svestak M, Sporova L, Hejduk P, Lacnak B, Stejskal D (2010) Collagenous repeat-containing sequence of 26 kDa protein - a newly discovered adipokine – sensu 1162 Li et al. lato - A minireview. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 154: 199-202.
15. Li ZY, Wang P, Miao CY (2011) Adipokines in inflammation, insulin resistance and cardiovascular disease. Clin Exp Pharmacol Physiol 38:888-896.
16. Liu M, Liu F (2012) Up- and down-regulation of adiponectin expression and multimerization: mechanisms and therapeutic implication. Biochimie 94: 2126- 2130.
17. Pajvani UB, Du X, Combs TP, Berg AH, Rajala MW, et al. (2003) Structure-function studies of the adipocyte-secreted hormone Acrp30/adiponectin. Implications for metabolic regulation and bioactivity. J Biol Chem 278:9073-9085.
18. Ozeki N, Hara K, Yatsuka C, Nakano T, Matsumoto S, et al. (2009) Serum high-molecular weight adiponectin decreases abruptly after an oral glucose load in subjects with normal glucose tolerance or impaired fasting glucose, but not those with impaired glucose tolerance or diabetes mellitus. Metabolism 58:1470-1476.
19. Liu M, Zhou L, Xu A, Lam KS, Wetzel MD, et al. (2008) A disulfide-bond A oxidoreductase-like protein (DsbA-L) regulates adiponectin multimerization. Proc Natl Acad Sci USA 105:18302-18307.
20. Liu M, Xiang R, Wilk SA, Zhang N, Sloane LB, et al. (2012) Fat-specific DsbA-L overexpression promotes adiponectin multimerization and protects mice from diet-induced obesity and insulin resistance. Diabetes 61: 2776-2786.
21. Wang A, Liu M, Liu X, Dong LQ, Glickman RD, et al. (2011) Up-regulation of adiponectin by resveratrol: the essential roles of the Akt/FOXO1 and AMP-activated protein kinase signaling pathways and DsbA-L. J Biol Chem 286: 60-66.